Evidence map›Paper›PMID 35809152›Full record

ArticleInternal and emergency medicine2022

Comparison of the characteristics, morbidity and mortality of COVID-19 between first and second/third wave in a hospital setting in Lombardy: a retrospective cohort study.

Francesca Leidi, Gianluca Edoardo Mario Boari, Ottavio Scarano, Benedetta Mangili, Giulia Gorla, Andrea Corbani, Beatrice Accordini, Federico Napoli, Chiara Ghidelli, Giulia Archenti and 14 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Internal and emergency medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Identifying Predominant Causes of Death Among Hospitalized COVID-19 Patients During Poland's Second and Third Waves.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Beware the IBM SPSS statisticsInternal and emergency medicine · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Observational
  14. Observational
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Francesca Leidi *Division of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Gianluca Edoardo Mario Boari *Division of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Ottavio ScaranoDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Benedetta MangiliDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Giulia GorlaDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Andrea CorbaniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Beatrice AccordiniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Federico NapoliDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Chiara GhidelliDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Giulia ArchentiDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Daniele TuriniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Michele SaottiniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Vittoria GuarinoniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Giulia Ferrari-ToninelliDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Francesca ManzoniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Silvia BonettiDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Giulia ChiariniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Paolo MalerbaDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Federico Braglia-OrlandiniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Gianluca BiancoDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Cristina FaustiniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy.
Claudia Agabiti-RoseiDepartment of Clinical and Experimental Sciences, University of Brescia, c/o 2a Medicina Spedali Civili Di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy.
Carolina De CiuceisDepartment of Clinical and Experimental Sciences, University of Brescia, c/o 2a Medicina Spedali Civili Di Brescia, Piazza Spedali Civili 1, 25100, Brescia, Italy.
Damiano RizzoniDivision of Medicine, Spedali Civili di Brescia, Montichiari, Brescia, Italy. damiano.rizzoni@unibs.it.ORCID http://orcid.org/0000-0002-1253-0186
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) represents a major health problem in terms of deaths and long-term sequelae. We conducted a retrospective cohort study at Montichiari Hospital (Brescia, Italy) to better understand the determinants of outcome in two different COVID-19 outbreaks. A total of 634 unvaccinated patients admitted from local emergency room to the Internal Medicine ward with a confirmed diagnosis of SARS-CoV-2 infection and a moderate-to-severe COVID-19 were included in the study. A group of 260 consecutive patients during SARS-CoV-2 first wave (from February to May 2020) and 374 consecutive patients during SARS-CoV-2 2nd/3rd wave (from October 2020 to May 2021) were considered. Demographic data were not significantly different between waves, except a lower prevalence of female sex during first wave. Mortality was significantly higher during the 1

Indexed as

COVID-19AngiotensinsAnti-Bacterial AgentsAntihypertensive AgentsC-Reactive ProteinFemaleHeparinHospital MortalityHospitalsHumansMaleMorbidityOxygenProcalcitoninRetrospective StudiesSARS-CoV-2AngiotensinsAnti-Bacterial AgentsAntihypertensive AgentsC-Reactive ProteinHeparinOxygenProcalcitoninCOVID-19MortalityPrognostic factorsSARS-CoV2Waves

Identifiers

PMID35809152
PMCPMC9521559
OpenAlexW4284960573

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.